Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium.

dc.contributor.authorKoivula, R. W.en
dc.contributor.authorHeggie, A.en
dc.contributor.authorBarnett, A.en
dc.contributor.authorCederberg, H.en
dc.contributor.authorHansen, T. H.en
dc.contributor.authorKoopman, A. D.en
dc.contributor.authorRidderstråle, M.en
dc.contributor.authorRutters, F.en
dc.contributor.authorVestergaard, H.en
dc.contributor.authorGupta, R.en
dc.contributor.authorHerrgård, S.en
dc.contributor.authorHeymans, M. W.en
dc.contributor.authorPerry, Mandyen
dc.contributor.authorRauh, S.en
dc.contributor.authorSiloaho, M.en
dc.contributor.authorTeare, H. J. A.en
dc.contributor.authorThorand, B.en
dc.contributor.authorBell, J.en
dc.contributor.authorBrunak, S.en
dc.contributor.authorFrost, G.en
dc.contributor.authorJablonka, B.en
dc.contributor.authorMari, A.en
dc.contributor.authorMcDonald, Timothy J.en
dc.contributor.authorDekker, J. M.en
dc.contributor.authorHansen, T. V. O.en
dc.contributor.authorHattersley, Andrew T.en
dc.contributor.authorLaakso, M.en
dc.contributor.authorPedersen, O.en
dc.contributor.authorKoivisto, V.en
dc.contributor.authorRuetten, H.en
dc.contributor.authorWalker, M.en
dc.contributor.authorPearson, E. R.en
dc.contributor.authorFranks, P. W.en
dc.date.accessioned2016-08-08T10:29:54Z
dc.date.available2016-08-08T10:29:54Z
dc.date.issued2014-06
dc.description.abstractThe DIRECT (Diabetes Research on Patient Stratification) Study is part of a European Union Framework 7 Innovative Medicines Initiative project, a joint undertaking between four industry and 21 academic partners throughout Europe. The Consortium aims to discover and validate biomarkers that: (1) predict the rate of glycaemic deterioration before and after type 2 diabetes onset; (2) predict the response to diabetes therapies; and (3) help stratify type 2 diabetes into clearly definable disease subclasses that can be treated more effectively than without stratification. This paper describes two new prospective cohort studies conducted as part of DIRECT.en
dc.description.noteThis article is freely available via Open Access. Click on the 'Additional Link' above to access the full-text via the publisher's site.en
dc.identifier.citationDiscovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium. 2014, 57 (6):1132-42 Diabetologiaen
dc.identifier.doi10.1007/s00125-014-3216-x
dc.identifier.issn1432-0428
dc.identifier.journalDiabetologiaen
dc.identifier.pmid24695864
dc.identifier.urihttp://hdl.handle.net/11287/618023
dc.language.isoenen
dc.publisherSpringeren
dc.relation.urlhttp://dx.doi.org/10.1007/s00125-014-3216-xen
dc.rightsArchived with thanks to Diabetologiaen
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.::Geneticsen
dc.subjectWessex Classification Subject Headings::Endocrinology::Diabetesen
dc.titleDiscovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium.en
dc.typeJournal Articleen
dc.typeResearch Support, Non-U.S. Gov'ten
dc.type.versionPublisheden
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.92 KB
Format:
Item-specific license agreed upon to submission
Description: